Synthetic biology lab backed by £2 million award
- Posted on 3 April, 2014
Scientists at the University of Liverpool have been awarded £2M to build a state-of-the-art DNA synthesis facility, a capability offering much needed tools for genome engineering to the academic and private sectors.
This facility, named GeneMill will be part of the UK’s focus on synthetic biology, identified by the Government as one of the ‘Eight Great Technologies’ in which Britain is, or can be, a world leader.
Synthetic biology involves the construction of artificial biological devices, pathways or networks or the re-engineering of existing natural ones. Key to this engineering process is the construction of parts or components, which are encoded in DNA. One of the biggest hurdles in synthetic biology is the creation and assembly of starting materials: modular bits of DNA that code for a particular function and are synthesised in the lab.
Creating such starting materials is time-consuming and expensive and a challenge that the Liverpool group of scientists will address through the GeneMill. Like traditional mills, scientists will take in raw materials and use them to create new products.
Share this article:
Related partners
People also read
BBC highlight Modern Synthesis
Ben Reeve from Modern Synthesis and Tom Ellis from the Department of Bioengineering, Imperial College are featured on the One Show talking about the m...
BBC Click Combatting Cancer
BBC Click meets the scientists harnessing the power of robotics and AI to find new cancer treatments with fewer side effects. See James Field from Lab...
New Government report
UK Government report published this week entitled “Engineering Biology: Opportunities for the UK Economy and National Goals”, is an important document...